Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

CVS Health Announces Board Changes

$CVSPress releaseAug 17, 2026, 4:15 PM ETRead the release

CVS Health appointed Teresa Heitsenrether, Executive Vice President and Chief Data & Analytics Officer at JPMorgan Chase, to its Board of Directors effective November 18, 2026. Heitsenrether replaces Larry Robbins, CEO of Glenview, who departed the Board on August 13, 2026, after serving since 2024.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.